51. Alpharetroviral self-inactivating vectors: an emerging tool for gene therapy. Issue 5 (2016) Journal: Cell & gene therapy insights Issue: Volume 2:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. An academic model for cell and gene therapy asset development. Issue 1 (2019) Authors: DiGiusto, David Journal: Cell & gene therapy insights Issue: Volume 5:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. An alternative to patents: can DNA be protected by copyright and design right law?. Issue 8 (2017) Authors: Martin, Beatriz San; Hurdle, Heidi Journal: Cell & gene therapy insights Issue: Volume 3:Issue 8(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. An educated approach: AI-enabled neoantigen vaccine R&D. Issue 4 (2020) Journal: Cell & gene therapy insights Issue: Volume 6:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. An Industry Perspective on the Clinical Preparation of Cell Therapies. Issue 2 (2016) Authors: Murphy, Brian Journal: Cell & gene therapy insights Issue: Volume 2:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS. Issue 11 (2020) Journal: Cell & gene therapy insights Issue: Volume 6:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. An outcomes-based, innovative reimbursement mechanism for curative medicines. Issue 8 (2019) Journal: Cell & gene therapy insights Issue: Volume 5:Issue 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Analysing clinical trends for cell & gene therapy in neurodegenerative diseases. Issue 1 (2020) Journal: Cell & gene therapy insights Issue: Volume 6:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Analytical approaches to characterize AAV vector production & purification: Advances and challenges. Issue 2 (2018) Authors: Dorange, Fabien; Bec, Christine Le Journal: Cell & gene therapy insights Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Analytical considerations for cellular therapy manufacturing. Issue 6 (2016) Authors: Wiwi, Chris Journal: Cell & gene therapy insights Issue: Volume 2:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗